FdaApplication

ANDA 202122

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTEVA PHARMACEUTICALS USA
application_typeANDA
approval_date2014-08-26

Products (2)

ProductActive ingredientStrengthDosage form
ENTECAVIRENTECAVIR0.5MGTABLET;ORAL
ENTECAVIRENTECAVIR1MGTABLET;ORAL

2 products